81.JPG)
The Spatial Omics Solutions Market Size is valued at USD 276.5 Million in 2023 and is predicted to reach USD 671.59 Million by the year 2031 at a 12.4 % CAGR during the forecast period for 2024-2031.
Spatial omics consists of Proteomics, epigenomics, transcriptomics, Genomics, metabolomics and lipidomic. The field of spatial omics combines molecular analysis with geographical information concerning the location of a cell inside a tissue. As a result, this technology provides a powerful instrument for studying essential phenomena such as tissue organization and cell regulation. The spatial profiling-based techniques permit the analysis of the tissue microenvironment and the tumour's biology, and it is also possible to evaluate the tissue biomarkers.
All The fields of Spatial omics have gained prominence in recent years as neurological ailments, and rare diseases have become more widespread worldwide. More than one hundred mRNAs from a single formalin-fixed paraffin-embedded (FFPE) tissue or frozen tissue section are currently being developed by several contract research organizations using spatial profiling-based services. This development will allow for simultaneous in-situ spatial analysis of multiple biomarker proteins.
The increasing prevalence of a wide variety of genetic disorders, global technological advancements in sequencing technologies, and an increase in research funding in spatial omics are all factors driving the market. Increases in the use of spatial OMICS in drug discovery and development, as well as the growth potential of spatial OMICS as a tool for diagnosing cancer, are expected to drive growth in the market for spatial OMICS. Spatial transcriptomics is progressively displaying potential for resolving the constraints of both bulk and single-cell RNA sequencing through the utilization of spatially barcoded microarray probes to capture and sequence mRNA from frozen tissue sections. In the summer of 2022, Bruker Corporation revealed a slew of advancements for spatial multiomics, emphasizing unbiased Spatial Single-Cell Metabolomics (SSCM), a technique that uses the metabolic signature of tissues and individual cells to look for differences in cell phenotypes.
High capital requirements, which hinder the expansion of global reach, and a lack of tools for computational analysis are the two primary factors contributing to market restraints. Also, many factors could limit the market's growth, including a shortage of experienced professionals and a lack of awareness of modern spatial-based technology.
Market Segmentation
The Spatial Omics market is segmented by solution type, sample analyzed, application and end-user. All of these segments are subdivided into respective segments. The solution type segment has instruments, consumables and services, respectively. The sample analyzed category comprises DNA, RNA, and Protein samples. Also, the application segment includes diagnosis, translation research, drug discovery and development, single cell analysis, cell biology and other applications. The last segment is the end-user segment which contains Academic and Research Institutions, Biopharmaceutical and Biotechnological Companies, Contract Research Organizations and other end-users.
North America has the highest share of the spatial omics market because of improving healthcare infrastructure, rising per capita income, and the availability of state-of-the-art research laboratories and institutes in the area.
Competitive Landscape
Some Major Key Players In The Spatial Omics Solutions Market:
- Fluidigm Corporation
- 10x Genomics, Inc.
- Bruker
- Canopy Biosciences
- NanoString Technologies, Inc.
- Bio-Techne Corporation
- Flagship Biosciences, Inc
- Akoya Biosciences, Inc.
- Rebus Biosystems
- BioSpyder Technologies
- S2 Genomics, Inc.
- IONpath, Inc.
- Miltenyi Biotec
- RareCyte, Inc.
- Visikol, Inc.
- Illumina Inc.
- Bio-Rad Laboratories, Inc.
- Fluidigm Corporation
- Genomic Vision
- Seven Bridges Genomics
- Resolve Biosciences
- Readcoor, Inc.
- Lunaphore Technologies
- Molecular Machines & Industries (MMI)
- Dovetail Genomics
- Vizgen Corp.
- Optical Biosystems, Inc.
- Ultivue, Inc.
- Cytiva
Spatial Omics Solutions Market Report Scope
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 276.5 Million |
|
Revenue Forecast In 2031 |
USD 671.59 Million |
|
Growth Rate CAGR |
CAGR of 12.4 % from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
Solution Type, Sample Analyzed, Application, End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
Standard BioTools (Fluidigm Corporation), 10x Genomics, Inc., Bruker, Canopy Biosciences, NanoString Technologies, Inc., Bio-Techne Corporation, Flagship Biosciences, Inc, Akoya Biosciences, Inc., Rebus Biosystems, BioSpyder Technologies, S2 Genomics, Inc., IONpath, Inc., Miltenyi Biotec, RareCyte, Inc., Visikol, Inc., Illumina Inc., Bio-Rad Laboratories, Inc., Fluidigm Corporation, Genomic Vision, Seven Bridges Genomics, Resolve Biosciences, Readcoor, Inc., Lunaphore Technologies, Molecular Machines & Industries (MMI), Dovetail Genomics, Vizgen Corp., Optical Biosystems, Inc., Ultivue, Inc., Cytiva |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
